Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Inovise Medical: Additional $12.5 in funding announced Feb. 12 brings total equity investment to $22 mil. Proceeds go toward final development, sales and marketing activities for the Cardiovise DEC system, used to diagnose heart disease. Product is expected to be available in the U.S. by year-end. Founded in 1997 by Hewlett Packard executives, the Inovise's proprietary digital electroacoustic cardiography technology combines electrical and sound information to diagnose abnormal heart conditions, including coronary artery disease, heart failure, acute coronary syndrome and left ventricular hypertrophy. New investors MDS Capital Corp. and TAT Capital Partners, Ltd. led the secondary financing round...